as of 12-10-2025 3:46pm EST
Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.
| Founded: | 2019 | Country: | United States |
| Employees: | N/A | City: | SALT LAKE CITY |
| Market Cap: | 347.4M | IPO Year: | 2024 |
| Target Price: | $4.50 | AVG Volume (30 days): | 13.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.63 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.43 - $34.77 | Next Earning Date: | 11-19-2025 |
| Revenue: | $1,980,278 | Revenue Growth: | -31.13% |
| Revenue Growth (this year): | -33.16% | Revenue Growth (next year): | 2774.04% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
NAKA Breaking Stock News: Dive into NAKA Ticker-Specific Updates for Smart Investing
AI Sentiment
Negative
3/10
See how NAKA stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "NAKA Kindly MD Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.